Questions on variant Creutzfeldt–Jakob disease and blood transfusion
Two developments in the field of variant Creutzfeldt–Jakob disease (vCJD) occurred in 2009. In order to address a number of questions that were raised, ECDC internal and external experts prepared this risk assessment. The document focuses on how these new facts affect the current assumptions regarding transmissibility of the disease through blood transfusion and tissue/cells transplantation.
Risk assessment: The risk of variant Creutzfeldt-Jakob disease transmission via blood and plasma-derived medicinal products manufactured from donations obtained in the United Kingdom
3 Aug 2021 - ECDC assessed the risk to the EU/EEA of the presence and the possible transmission of prions, which have been linked to to Creutzfeldt-Jakob disease, by blood and plasma-derived medicinal products (PDMPs) manufactured from donations obtained in the UK.
Rapid Risk Assessment: Extreme rainfall and catastrophic floods in western Europe
29 Jul 2021 - Extreme rainfall on 14 and 15 July 2021 and subsequent flooding in Western Europe has taken a high number of human lives and caused substantial damage to community infrastructure and the environment. This rapid risk assessment focuses on the most common infectious diseases and health risks associated with flood-affected areas, taking into account evidence from previous similar events in Europe.
Rapid Risk Assessment: COVID-19 outbreaks in long-term care facilities in the EU/EEA in the context of current vaccination coverage
26 Jul 2021 - Coronavirus disease (COVID-19) outbreaks in long-term care facilities (LTCFs) in European Union and European Economic Area (EU/EEA) countries have caused significant morbidity and mortality since the beginning of the COVID-19 pandemic.